RPIDx™
AI-Driven
Biopsy Results in 5 minutes™
Paving the Way for Point of Biopsy (POB) Diagnostics
These statements have not been evaluated by the FDA and product images are for illustrative purposes only. This product is not available for sale and is currently in research and development.
Our Vision
A future where patients never have to wait for a cancer diagnosis.
Our Mission
Accelerate cancer care by providing immediate diagnostic biopsy results.
The Problem: Biopsy Results Take Too Long
Cancer biopsy diagnosis is a time-consuming and elaborate process that can take between 1 to 2 weeks.
“The agony of waiting for diagnostic results constantly weighed on me, as I could never immediately begin life-saving treatment on our patients.”
Founder and CEO
- Rachel Wellner, MD, MPH, FACS
Our Solution: RPIDx™
Real-time AI-assisted cancer diagnosis
First in kind, AI-based diagnostic device capable of yielding functional pathology results in 5 minutes
No need for an on-site pathologist
Accepted, higly accurate (>95%) FLIM-based metabolic activity distinction between cancer (and phenotypic subtypes) and benign cells
Fully automated diagnosis; no human analysis
Point-of-care rapid diagnosis adjacent to the patient bedside
No additional training needed for hospital staff
No contrast injected into the patient
Patent approved
These statements have not been evaluated by the FDA. Product images are for illustrative purposes only. This product is not available for sale and is currently in research and development.
RPIDx™
Intended for all medical centers diagnosing cancer
Cancer Centers
Community-based hospitals
Ambulatory surgical centers
Interventional radiology clinics
Dermatology and medical offices
These statements have not been evaluated by the FDA and product images are for illustrative purposes only. This product is not available for sale and is currently in research and development.